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Abstract
Background: Fluorescence in situ hybridization (FISH) is very accurate method for measuring HER2 gene copies, as
a sign of potential breast cancer. This method requires small tissue samples, and has a high sensitivity to detect
abnormalities from a histological section. By using multiple colors, this method allows the detection of multiple
targets simultaneously. The target parts in the cells become visible as colored dots. The HER-2 probes are visible as
orange stained spots under a fluorescent microscope while probes for centromere 17 (CEP-17), the chromosome
on which the gene HER-2/neu is located, are visible as green spots.
Methods: The conventional analysis involves the scoring of the ratio of HER-2/neu over CEP 17 dots within each
cell nucleus and then averaging the scores for a number of 60 cells. A ratio of 2.0 of HER-2/neu to CEP 17 copy
number denotes amplification. Several methods have been proposed for the detection and automated evaluation
(dot counting) of FISH signals. In this paper the combined method based on the mathematical morphology (MM)
and inverse multifractal (IMF) analysis is suggested. Similar method was applied recently in detection of
microcalcifications in digital mammograms, and was very successful.
Results: The combined MM using top-hat and bottom-hat filters, and the IMF method was applied to FISH images
from Molecular Biology Lab, Department of Pathology, Wielkoposka Cancer Center, Poznan. Initial results indicate
that this method can be applied to FISH images for the evaluation of HER2/neu status.
Conclusions: Mathematical morphology and multifractal approach are used for colored dot detection and
counting in FISH images. Initial results derived on clinical cases are promising. Note that the overlapping of colored
dots, particularly red/orange dots, needs additional improvements in post-processing.
Background
Breast cancer is the most common cancer for women
worldwide, comprising 16% of all female cancers. From
reports of the World Health Organization (WHO) [1],
more than one million cases of breast cancer are diag-
nosed every year, mainly (about 75 percent) for women
aged 50 and older. Since breast cancer typically spreads
from the breast to lymph nodes and then to distant
parts of the body (metastasis), very often such spreading
can occur prior to the detection of primary cancer.
Breast cancer survival rates vary greatly worldwide, ran-
g i n gf r o m8 0 %o ro v e ri nd e v e l o p e dc o u n t r i e s( N o r t h
America, Sweden and Japan) to around 60% in middle-
income countries and below 40% in low-income coun-
tries [2]. The survival is greatly improved if the breast
anomalies are detected at early stages through breast
self exams and/or mammography [1].
In the late 1980s, researchers discovered that approxi-
mately 20 percent of women with breast cancer produce
abnormally high amounts of a protein called human epi-
dermal growth factor receptor 2 (HER2), also known as
HER2/neu, a member of the HER family of receptor
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affecting to their growth and differentiation. A healthy
breast cell has 2 copies of the HER2 gene. Some kinds
of breast cancer get started when a breast cell has more
than 2 copies of that gene (this process is called the
amplification), and those copies start over-producing
the HER2 protein. As a result, the affected cells grow
and divide much too quickly [3].
Amplification of HER2 is associated with a poor prog-
nosis (higher rate of recurrence and mortality) and is
usually associated with resistance to endocrine therapies.
Fortunately, after more decade of research, a drug Her-
ceptin (generic name trastuzmab) was discovered and
approved for use by the U.S. Food and Drug Adminis-
tration (FDA) in September 1998, which can be very
successful in treatment of advanced breast cancer just
for women whose breast cancer cells carry extra copies
of a HER2. This drug, given intravenously, once every 2-
3 weeks, targets the HER2 protein production. This
helps to stop the growth of the HER2 positive cancer
cells. Herceptin has shown great promise in increasing
patient survival time and reducing the number of deaths
from advanced breast cancer. Clinical trials are also
investigating whether Herceptin is helpful for women
with early-stage breast cancers [4], [5].
Accurate determination of Her-2/neu status in breast
carcinoma is essential for therapy planning. Nowadays,
the two most widely technologies for the evaluation of
HER2 status are immunohistochemistry (IHC) and
fluorescence in situ hybridization (FISH). The IHC mea-
sures the expression of the HER2 protein on the surface
of the tumor cell while FISH measures the amplification
of the HER2/neu gene present in the cells. The IHC
uses low-cost standard microscope observation [6] but
this method is more subjective, whereas FISH technique
needs more specialized equipment than immunohisto-
chemistry does, but is more objective and permits even
automated evaluation [7], [8].
Fluorescence is a physical property of some materials,
based on the quantum transitions. When illuminated at
specific wavelengths (energy), such materials are excited
and, in relaxation phase, emit light, usually at lower
wavelengths (lower energy). Different fluorescent mar-
kers have been developed for detection specific cells,
parts of cells, nuclei and chromosomes. For instance,
nuclei can be detected after the treatment with diamidi-
nophenylindole (DAPI), a fluorescent marker that emits
blue light [9]. The FDA approved PathVision Her2 FISH
kit (Vysis, Downers Grove, USA) uses DNA probes,
which are small segments of actual DNA material.
When applied to a tumor tissue sample, these DNA
probes target the HER-2/neu gene and attach them-
selves to their target sequence. This process is called
hybridization. The probes carry special fluorescent
markers that emit light, when the probes bind to the
HER-2 genes. The HER-2 probes are visible as orange
stained spots under a fluorescent microscope. Similarly,
probes for centromere 17 (CEP-17), the chromosome on
which the gene HER-2/neu is located, are visible as
green spots.
Fluorescence microscopy differs from classic optic
microscopy. In classic microscopy, the sample to visua-
lize is placed between a source of visible light and the
observer. The light is either reflected from the sample
(as in mineralogy) or transmitted through the thin tissue
(as in cytology). Fluorescence microscopy uses some
indirect method, as follows. A high-intensity UV light is
directed at the sample; the fluorescent markers in use
emit light at specific visible wavelengths; these signals
are then observed through adapted filters. The fluores-
cent signals obtained are recorded on a charge-coupled
device (CCD) camera, resulting in as many grayscale
images as the number of filters used.
The process of evaluating HER-2/neu status from
FISH images involves the manual counting of signals in
interphase nuclei which become visible as colored dots.
The conventional analysis involves the scoring of the
ratio of HER-2/neu over CEP 17 dots within each cell
nucleus and then averaging the scores for a number of
cells. Several images usually need to be read to reach
the desired number of dot-including nuclei. A ratio of
HER-2/neu to CEP 17 copy number greater than 2.2
denotes amplification, the ratio less than 1.8 denotes
normal state, while results between 1.8 and 2.2 are sus-
picious and need additional investigations [10].
Automated evaluation of HER2/neu status
Manual evaluation of HER2/neu status from FISH
i m a g e sm a yb ed i f f i c u l tt a s ks i n c ed o tc o u n t i n go v e ra
large number of nuclei and over different tissue sam-
ples is time consuming and tiresome procedure. More-
over, this procedure needs skilled person for this
imaging technique. Nowadays, the equipment for ana-
lysis of FISH images permits some kind of semi-auto-
matic analysis with the aid of image processing
software, which can display different color channels
and apply thresholds for nuclei segmentation. But, the
dot counting still remains a difficult procedure for a
physician, because nuclei can be poorly segmented,
overlapped or clustered [11].
Several systems for automatic detection and evaluation
of FISH images are reported [12], [13]. These systems
usually use different color channels from RGB image for
segmenting and extracting nuclei (in blue channel) and
then detecting and counting red/orange (HER2/neu)
and green (CEP 17) dots within the segmented nuclei.
Although the procedure seems to be easy, in practice a
lot of difficulties arise: one of the most severe task is to
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approach is reported in [14] where the author described
deep analysis of the structure of FISH images and sug-
gested the novel segmentation method permitting very
high accuracy of more than 99% on the dataset contain-
ing about 14,000 samples.
Methods
Detecting relatively small bright dots within the digital
image was under the investigation of our recent research
targeted to the detection of microcalcifications in digital
(or digitized) mammograms [15-17]. By using combined
mathematical morphology and multifractal methods we
obtained very good detection of microcalcifications even
i nt h ec a s eo fr a d i o l o g yh a r dc a s e s– when the breast
tissue was very dense [17]. In this paper we will apply
similar procedure for detecting and counting fluorescent
dots in FISH images.
T h ea s s u m p t i o ni no u rp r o c e d u r ei st oh a v eF I S H
images treated with the PathVision Her2 FISH kit. Typi-
cal example is depicted in Fig. 1-a. The first step is to
segment parts which can be nuclei from the blue chan-
n e lo ft h eR G Bi m a g e ,F i g .1 - b .O v e r l a p p e dp a r t sa r e
separated by applying watershed procedure, Fig. 1-c.
Selected objects as in Fig. 2-c are analyzed regarding to
their shape and size, and objects which are not nuclei
are removed, and nuclei are indexed, Fig. 1-d. After
that, the colored dots within segmented nuclei are
detected and counted. Since colored dots are displayed
as bright dots in monochrome images, dots detection
was performed by using the two methods similar as
in our previous work when detecting microcalcifications
[17].
First method is based on mathematical morphology
(MM). Instead of applying only top-hat (TH) filter, as
usually used for extracting bright spots, we suggested
the combination of top-hat and bottom-hat (BH) filters.
The top-hat is defined as the difference of the original
image, I, and its opening, while the bottom-hat is
defined as the image closing minus the original image.
In this way, the TH filter is an excellent tool for enhan-
cing small bright details from a nonuniform background.
Consequently, the BH filter produces an opposite effect:
one can extract dark features from a brighter back-
ground. Note that both filters also equalize a nonuni-
form background illumination. Moreover, local contrast
enhancement with high suppression of surrounding tex-
ture can be achieved by adding the difference of TH and
BH images to the original image. By the difference (TH
– BH) only details brighter than surrounding and smal-
ler than structuring element are strongly emphasized
while background tissue is highly suppressed. In fact,
the gray level of previously emphasized details is
increased toward white, while the overall gray level of
A

B

C D
Figure 1 Illustration of the process of nuclei segmentation and indexing.
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more, if we add an original image to this difference,
enhanced details become even brighter than surround-
ing. Consequently, the enhancement of bright details
smaller than the structuring element is reinforced, and
uneven background (surrounding tissue texture) is
highly equalized, almost regardless of overall surround-
ing brightness, as shown in [17].
The second method is based on the multifractal (MF)
analysis. MF approach is an efficient way for quantitative
description of complex structures, objects and phenom-
ena, such as clouds, the structure of nervous system,
coast-line structures, movements in global market, etc.
Such objects and phenomena exhibit interesting prop-
erty known as self-similar or fractal property: a struc-
ture is assumed as made of parts similar to the whole,
exactly or statistically. We can distinguish two main
groups of fractal structures: artificial and natural. Artifi-
cially generated fractal structures are commonly known
as deterministic (or, mathematical) fractals [18],[19].
These structures are generated by using exact rules and
they are characterized by exactly the same fractal
dimension in whole scales, thus they are referred as
monofractals.
Instead, a variety of natural objects may also exhibit self-
similarity but only in some statistical sense. These struc-
tures are known as random fractals.T h ef r a c t a ld i m e n s i o n
of such structures varies with the observed scale, thus they
are referred as multifractals[19]. Fractal and multifractal
properties of observed structure can be quantitatively
described in several ways, as reported in [19-22]. After
determining local regularity of the structure, for instance,
through the quantity known as Hölder exponent, a,w e
can calculate the distribution of this quantity, which is
known as the multifractal spectrum, f(a). The MF spec-
trum describes the global regularity of observed structure.
The MF analysis permits us to describe signal/struc-
ture features both from local and global points of view.
For instance, high values of Hölder exponent a denote
high local changes, and opposite for low a. Regarding to
the MF spectrum f(a), its low values denote rare events
– isolated parts in the whole structure having particular
value of a,a n do p p o s i t ef o rh i g hf(a). Moreover, the
MF analysis may be performed in an inverse way: find
parts in the signal/structure having particular values of
a or f(a). This kind of processing may be called as an
inverseMF (IMF) analysis. Brief description of the IMF is
as follows. For given image I,s i z e dMxN pixels, we can
create an ‘a-image’–a matrix of the same size MxN
but filled by values of a(i,j) with one-by-one correspon-
dence with image pixels I(i,j), i=1,2...,M; j=1,2,...,N. From
the a matrix, the MF spectrum f(a), also in a matrix
form, f(i,j)=f(a(i,j)), may be determined. From once cre-
ated a and f(a) matrices (images), we can select desired
range of values a and/or f(a), extracting in this way
image parts characterized just by these multifractal
values [21-24]. For instance, normal human tissue is
characterized by high degree of self-similarity[19], while
t h et i s s u ea n o m a l i e sm a yb ec o n s i d e r e da ss t r u c t u r a l
“defects”, i.e., as deviations from global regularity of the
background. This method is applied successfully for
enhancing and detecting microcalcifications in digital
mammograms [16]. Moreover, the efficiency of this
method was recognized by Levy Vehel, from INRIA,
France, and our program was embedded in their soft-
ware package FracLab as an additional tool [25].
Regarding to FISH images, colored dots can be
assumed as parts characterized by high values of Hölder
exponent a (high local changes) and low values of its
distribution f(a) (rare events, in global sense). Under
these assumption, by applying IMF we can extract
colored dots from nuclei background.
Results
The two methods for detecting colored dots within seg-
mented nuclei in FISH images: mathematical morphol-
ogy (MM) method and inverse multifractal (IMF),
described briefly in previous section, are tested on FISH
images obtained from the Molecular Biology Lab,
Department of Pathology, Wielkopolska Cancer Center,
Poznan, POLAND. FISH images are evaluated by skilled
pathologist and tested by proposed methods. Results for
eight characteristic cases are displayed in Table 1. First
four cases are labeled by physician as amplified and the
rest are normal (non-amplified). As indicated in Table 1,
objective methods, particularly IMF method, are promis-
ing but need improvements. The IMF method is better
than MM: for all amplified cases the HER2/neu status
was greater than 2.0, and for non-amplified cases was
less than 1.8, except for the case 5. By using MM
Figure 2 C a s e5o fa n a l y z e dF I S Hi m a g e s .I m a g ew i t h o u tD A P I
marker.
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and 4 the HER2/neu status was 1.71 and 1.81, while for
non-amplified case 5 the value was even 5.14! By addi-
tional inspection it was found that this image was
obtained without DAPI, Fig. 2. Since the nuclei segmen-
tation was performed under the assumption of blue
channel, for this image our methods counted red dots
out from nuclei.
General remark regarding proposed methods is that
additional post-processing is necessary, particularly for
red channel. Namely, red dots are overlapped, as
depicted in Fig. 3 (case 1 in our analysis) and their
separation needs more sophistical processing, which will
be considered in our future research.
Conclusion
In this paper the two methods for detecting colored dots
within segmented nuclei in FISH images are considered:
the method based on the mathematical morphology and
the inverse multifractal method. Initial results are pro-
mising but need further improvements which will be
considered in our future work.
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